Volume 5, Issue S1 p. 126
Abstract
Free Access

561 Pharmacokinetic-pharmacodynamic modeling and simulation of darbepoetin alfa once-monthly dosing regimen for the design of clinical trials in anemic patients with chronic heart failure

B. Agoram

B. Agoram

Amgen Inc., Thousand Oaks, United States of America

Search for more papers by this author
M. Toupikov

M. Toupikov

Amgen Inc., Thousand Oaks, United States of America

Search for more papers by this author
First published: 20 July 2007
No abstract is available for this article.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.